<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39385068</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Unveiling Post-COVID-19 syndrome: incidence, biomarkers, and clinical phenotypes in a Thai population.</ArticleTitle><Pagination><StartPage>1132</StartPage><MedlinePgn>1132</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-10055-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-COVID-&#x2009;19 syndrome (PCS) significantly impacts the quality of life of survivors. There is, however, a lack of a standardized approach to PCS diagnosis and management. Our bidirectional cohort study aimed to estimate PCS incidence, identify risk factors and biomarkers, and classify clinical phenotypes for enhanced management to improve patient outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A bidirectional prospective cohort study was conducted at five medical sites in Hatyai district in Songkhla Province, Thailand. Participants were randomly selected from among the survivors of COVID-19 aged&#x2265;18 years between May 15, 2022, and January 31, 2023. The selected participants underwent a scheduled outpatient visit for symptom and health assessments 12 to 16 weeks after the acute onset of infection, during which PCS was diagnosed and blood samples were collected for hematological, inflammatory, and serological tests. PCS was defined according to the World Health Organization criteria. Univariate and multiple logistic regression analyses were used to identify biomarkers associated with PCS. Moreover, three clustering methods (agglomerative hierarchical, divisive hierarchical, and K-means clustering) were applied, and internal validation metrics were used to determine clustering and similarities in phenotypes.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">A total of 300 survivors were enrolled in the study, 47% of whom developed PCS according to the World Health Organization (WHO) definition. In the sampled cohort, 66.3% were females, and 79.4% of them developed PCS (as compared to 54.7% of males, p-value &lt;0.001). Comorbidities were present in 19% (57/300) of all patients, with 11% (18/159) in the group without PCS and 27.7% (39/141) in the group with PCS. The incidence of PCS varied depending on the criteria used and reached 13% when a quality of life indicator was added to the WHO definition. Common PCS symptoms were hair loss (22%) and fatigue (21%), while mental health symptoms were less frequent (insomnia 3%, depression 3%, anxiety 2%). According to our univariate analysis, we found significantly lower hematocrit and IgG levels and greater ALP levels in PCS patients than in patients who did not develop PCS (p-value &lt; 0.05). According to our multivariable analysis, adjusted ALP levels remained a significant predictor of PCS (OR 1.02, p-value= 0.005). Clustering analysis revealed four groups characterized by severe clinical symptoms and mental health concerns (Cluster 1, 4%), moderate physical symptoms with predominant mental health issues (Cluster 2, 9%), moderate mental health issues with predominant physical symptoms (Cluster 3, 14%), and mild to no PCS (Cluster 4, 77%). The quality of life and ALP levels varied across the clusters.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">This study challenges the prevailing diagnostic criteria for PCS, emphasizing the need for a holistic approach that considers quality of life. The identification of ALP as a biomarker associated with PCS suggests that its monitoring could be used for early detection of the onset of PCS. Cluster analysis revealed four distinct clinical phenotypes characterized by different clinical symptoms and mental health concerns that 'exhibited varying impacts on quality of life. This finding suggested that accounting for the reduced quality of life in the definition of PCS could enhance its diagnosis and management and that moving toward personalized interventions could both improve patient outcomes and help reduce medicalization and optimally target the available resources.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">The research publication received funding support from&#xa0;Medical Council of Thailand (Police General Dr. Jongjate Aojanepong Foundation), Hatyai Hospital Charity and Wellcome Trust.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sangkaew</LastName><ForeName>Sorawat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Social Medicine, Hatyai Hospital, Songkhla, Thailand. sorawat.sa@cpird.in.th.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease, Section of Adult Infectious Disease, Imperial College London. Hammersmith Hospital Campus, London, W12 0NN, United Kingdom. sorawat.sa@cpird.in.th.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tumviriyakul</LastName><ForeName>Hathaitip</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Social Medicine, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheranakhorn</LastName><ForeName>Chutima</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Songumpai</LastName><ForeName>Nopporn</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinpathomrat</LastName><ForeName>Nawamin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeyankem</LastName><ForeName>Bunya</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasharad</LastName><ForeName>Kameelah</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Office of Disease Prevention and Control Region 12, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loomcharoen</LastName><ForeName>Palanthorn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakdee</LastName><ForeName>Wisitsak</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Changawej</LastName><ForeName>Chanunya</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nursing, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumrongkullachart</LastName><ForeName>Dararat</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nursing, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limheng</LastName><ForeName>Amornrat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Nursing, Hatyai Hospital, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorigatti</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095224" MajorTopicYN="N">Southeast Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Clinical phenotypes</Keyword><Keyword MajorTopicYN="N">Cluster analysis</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 Syndrome</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385068</ArticleId><ArticleId IdType="pmc">PMC11465487</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-10055-2</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-10055-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.. Available from: https://covid19.who.int. Cited 2023 Nov 27.</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7 Available from: https://linkinghub.elsevier.com/retrieve/pii/S1473309921007039 . Cited 2024 Sep 21. .
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. Systematic Review of the Prevalence of Long COVID. Open Forum Infect Dis. 2023;10(7):ofad233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinical Med. 2023;55:101762. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2589537022004916. Cited 2023 Nov 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Malesevic S, Sievi NA, Baumgartner P, Roser K, Sommer G, Schmidt D, et al. Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19. Sci Rep. 2023;13(1):7717 Available from: https://www.nature.com/articles/s41598-023-34678-8.&#xa0;Cited 2023 Nov 27 .
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10175927</ArticleId><ArticleId IdType="pubmed">37173355</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMed. 2021;38:101019. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2589537021002996. Cited 2023 Nov 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17(3):e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1745516/ . Cited 2024 Jan 17. .
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291&#x2013;8 Available from: https://www.sciencedirect.com/science/article/pii/016517819190027M . Cited 2024 Jan 17 .
</Citation><ArticleIdList><ArticleId IdType="pubmed">2062970</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarten JR, Anderson P, Kuskowski MA, McPherson SE, Borson S. Screening for Cognitive Impairment in an Elderly Veteran Population: Acceptability and Results Using Different Versions of the Mini-Cog. J Am Geriatr Soc. 2011;59(2):309&#x2013;13 Available from: https://onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1111/j.1532-5415.2010.03249.x . Cited 2024 Jan 17.</Citation><ArticleIdList><ArticleId IdType="pubmed">21314650</ArticleId></ArticleIdList></Reference><Reference><Citation>A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7 | Anxiety Disorders | JAMA Internal Medicine | JAMA Network. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410326. Cited 2024 Jan 17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Un&#xfc;tzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9. Med Care. 2004;42(12):1194 Available from: https://journals.lww.com/lww-medicalcare/abstract/2004/12000/monitoring_depression_treatment_outcomes_with_the.6.aspx . Cited 2024 Jan 17.
</Citation><ArticleIdList><ArticleId IdType="pubmed">15550799</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727&#x2013;36 Available from: 10.1007/s11136-011-9903-x . Cited 2024 Jan 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7 https://linkinghub.elsevier.com/retrieve/pii/S1473309921007039.&#xa0; Cited 2023 Nov 27.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritsen JM, Bruus M. EPIDATA: Data entry system for use with Stata, SPSS, SAS, Excel, text formats. 2000. Available from: https://ideas.repec.org/c/boc/bocode/s415902.html</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available from: https://www.R-project.org/</Citation></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy H, Y&#x131;ld&#x131;r&#x131;m UM, Ergen P, G&#xfc;rel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021;34(6):e15175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646871</ArticleId><ArticleId IdType="pubmed">34708909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, de la Cerda MLR, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Ther Adv Infect Dis. 2022;9:20499361211069264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen R, Ashton REM, Ferraro FV, Skipper L, Bewick T, Leighton P, et al. Forming a consensus opinion to inform long COVID support mechanisms and interventions: a modified Delphi approach. ClinicalMed. 2023;62:102145. Available from: https://linkinghub.elsevier.com/retrieve/pii/S258953702300322X. Cited 2023 Nov 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10432807</ArticleId><ArticleId IdType="pubmed">37599906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74 Available from: https://eglj.springeropen.com/articles/10.1186/s43066-021-00144-1 . Cited 2023 Nov 29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med. 2023;10:1085988 Available from: https://www.frontiersin.org/articles/https://doi.org/10.3389/fmed.2023.1085988/full . Cited 2023 Nov 29 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Satiya J, Lenik JM, NV Bergasa. Increased Activity of Alkaline Phosphatase in COVID-19: Potential Mechanisms. SL Gastroenterology. 2022;4(2):134.</Citation></Reference><Reference><Citation>Kisiel MA, Lee S, Malmquist S, Rykatkin O, Holgert S, Janols H, et al. Clustering Analysis Identified Three Long COVID Phenotypes and Their Association with General Health Status and Working Ability. J Clin Med. 2023;12(11):3617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10253616</ArticleId><ArticleId IdType="pubmed">37297812</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>